1. Executive Summary
2. Research Methodology
3. 3D Bioprinting
3.1 Introduction
3.1.1 3D Bioprinting - History
3.2 Bioprinting - Components
3.2.1 3D Printing Software
3.2.2 3D Bioprinters
3.2.3 Biocompatible Materials
3.3 3D Bioprinting Process
3.4 Advantages
4. Global 3D Bioprinting Market Analysis
4.1 Market Sizing
4.1.1 Market Size by Value
4.2 Market Share
4.2.1 Market Share by Technology
4.2.2 Market Share by Application
4.2.3 Market Share by Tissue Type
4.2.4 Market Share by Region
4.3 Regional Analysis
4.3.1 Americas
4.3.2 EMEA
4.3.3 APAC
5. Global Bioprinting Market Segmentation
5.1 Technology
5.1.1 Syringe Extrusion 3D Bioprinting Market Analysis
5.1.2 Inkjet 3D Bioprinting
5.1.3 Laser-Assisted 3D Bioprinting
5.1.4 Magnetic Levitation-based 3D Bioprinting
5.1.5 Valve-based 3D Bioprinting
5.2 Biocompatible Materials
5.3 Application
5.3.1 Prosthetics & Implants
5.3.2 Regenerative Medicine
5.3.3 Tissue and Organ Regeneration Applications
5.3.4 Biosensors
6. Market Dynamics
6.1 Industry Trends & Development
6.1.1 Low Cost 3D Bioprinters
6.1.2 Decline in Cost of Biomaterial
6.1.3 Scaffold-free Bioprinting
6.1.4 Growing Tissue Grafts on Humanoid Robots
6.1.5 Advancing Bioprinted Human Liver as First Therapeutic Tissue
6.2 Growth Drivers
6.2.1 Organ Transplants: Demand-Supply Gap
6.2.2 Drug Toxicity Testing
6.2.3 Orthopedic Implants
6.3 Challenges
6.3.1 Regulatory Hurdles
6.3.2 Lack of Skilled Professionals
6.3.3 High Costs
6.3.4 Limited Choice of Biomaterials
7. Competitive Landscape
7.1 Bioprinting Company Analysis
7.2 Market Share by Competitors
7.3 Financial Analysis
8. Company Profiles
8.1 Organovo Holdings, Inc.
8.2 CELLINK AB
8.3 EnvisionTEC GmbH
8.4 BioBots, Inc.
8.5 Cyfuse Biomedical K.K.